Clinical Trial Update: Master Rollover Protocol for Continued Safety Assessment of Study Drug

View source ↗

Summary

This document outlines a master rollover protocol to continue safety assessment of the study drug in cancer trials. It describes ongoing safety monitoring activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Cancer | Status: AVAILABLE